Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia

Ítems similars

• Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation
  per: Metzgeroth, Georgia, et al.
  Publicat: (2020)
• FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
  per: Loules, Gedeon, et al.
  Publicat: (2009)
• A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia
  per: Oberley, Matthew J., et al.
  Publicat: (2017)
• Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
  per: Bain, Barbara J.
  Publicat: (2010)
• Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
  per: Ma, Rui, et al.
  Publicat: (2019)